Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits

REGISTER for free or LOG IN to view this content

Randomized comparison of Biolimus-eluting (Nobori)  and Everolimus-eluting (Xience/Promus)  stents in patients with multivessel coronary artery disease: 12-month follow-up data...

We Recommend